Poster presentations may not seem as prestigious as oral presentations, but they are a great opportunity to interact with other scientists in your field in a reasonably structured way. Just like oral ...
Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...
BOSTON, Oct. 23, 2024 /PRNewswire/ -- Nemdx, Inc. today announced a poster presentation at the 2024 Northeast ALS Annual Conference (NEALS) hosted online on October 21-24. The poster, presented by ...
Poster hang up: 9:30 a.m. - 10:00 a.m. Poster presentations: 10 a.m. - 12 p.m. Poster judging: 10 a.m. - 11 a.m. Awards presentation: 12:15 p.m. - 12:45 p.m. The ...
VoiceThread Recording Submission Deadline (for those accepted for Virtual and In-person Posters): Jan. 26, 2026 at 5 p.m. Upon abstract acceptance, all posters must be uploaded and recorded on ...
BeyondSpring (NASDAQ: BYSI) is a clinical-stage biopharmaceutical company developing first-in-class therapies for high unmet medical needs. Its lead asset, Plinabulin, is in late-stage clinical ...
It’s easy to feel awkward or overstimulated in a conference environment. Nature sought advice on how to avoid moments of panic while giving talks or discussing your research. I’m a PhD student ...
TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic ...
WILMETTE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative ...
FLORHAM PARK, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback